Re-irradiation in lung disease by SBRT: a retrospective, single institutional study

被引：11
|
作者：
Caivano, Donatella [1 ]
Valenani, Maurizio [2 ]
De Matteis, Sara [2 ]
Bonome, Paolo [2 ]
Russo, Ivana [3 ]
De Sanctis, Vitaliana [2 ]
Minniti, Giuseppe [4 ]
Osti, Mattia Falchetto [2 ]
机构：
[1] CNAO Natl Ctr Oncol Hadrontherapy, Dept Radiat Oncol, Str Campeggi 53, I-27100 Pavia, Italy
[2] Univ Rome Sapienza, St Andrea Hosp, Fac Med & Psicol, Dept Radiat Oncol, Via Grottarossa 1035-1039, I-00189 Rome, Italy
[3] UPMC San Pietro FBF, Ctr Radioterapia Alta Specializzaz, Via Cassia 600, I-00189 Rome, Italy
[4] Neuromed Mediterranean Neurol Inst, Via Atinense 18, I-86077 Pozzilli, IS, Italy
来源：
RADIATION ONCOLOGY | 2018年 / 13卷
关键词：
Re-irradiation; SBRT; Lung; Primary or metastatic disease; STEREOTACTIC ABLATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; TUMORS;
D O I：
10.1186/s13014-018-1041-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The loco regional relapse is frequent in the lung disease. The aim of this study was to evaluate the outcomes of re-irradiation by SBRT in terms of Local Control (LC) and toxicities. Methods: From April 2011 to December 2016, twenty-two patients received a re-irradiation by SBRT. Twenty-seven lesions were treated. The medium BED(10) of re-irradiation was 100.6 Gy (range: 48-151.2 Gy) and the medium EQD2 (10) was 93.8 Gy (range: 40-126 Gy). In the previous treatment the medium BED(10) was 97.2 Gy (range: 40-120 Gy), the medium EQD2(10) was 81 Gy (range: 32.5-100 Gy). The median time between the first and the second treatment was 18 months. Results: Local Control was reached in 18 out of 27 (66%) re-irradiated lesions, with rates of 67 and 54% at 1-year and 2-years respectively. The treatment was well tolerated; the maximum recorded toxicity was Grade 3. Conclusions: Re-irradiation by SBRT may represent an option for the treatment of lung disease with good results in terms of LC and toxicity.
引用
收藏
页数：8
相关论文
共 50 条
  • [21] Histopathological findings after irradiation and re-irradiation of spinal bone metastases with SBRT
    Foerster, R.
    Cho, B. C. J.
    Fahim, D. K.
    Gerszten, P. C.
    Flickinger, J. C.
    Grills, I. S.
    Jawad, M. S.
    Kersh, C. R.
    Letourneau, D.
    Mantel, F.
    Sahgal, A.
    Shin, J. H.
    Winey, B. A.
    Guckenberger, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S441 - S442
  • [22] Re-irradiation with SBRT for In-field Recurrence of Pancreatic Cancer After Prior SBRT
    Shen, Y.
    Zhu, X.
    Ju, X.
    Cao, Y.
    Qing, S.
    Cao, F.
    Zhang, H.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S417 - S418
  • [23] Re-Irradiation for Recurrent Pediatric CNS Malignancies: A Multi-Institutional Retrospective Review
    Rao, Avani D.
    Rashid, Arif
    Chen, Qinyu
    Villar, Rosangela C.
    Kobyzeva, Daria
    Nilsson, Kristina
    Dieckmann, Karin
    Nechesnyuk, Alexey
    Ermoian, Ralph
    Alcorn, Sara
    MacDonald, Shannon M.
    Ladra, Matthew M.
    Ford, Eric C.
    Winey, Brian A.
    Figueiredo, Maria Luisa S.
    Terezakis, Stephanie A.
    Chen, Michael J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E14 - E15
  • [24] A Retrospective Study of Re-irradiation (Re-RT) for Recurrent Medulloblastoma (MB)
    Bakst, R. L.
    Dunkel, I.
    Gilheeney, S.
    Khakoo, Y.
    Becher, O.
    Souweidane, M.
    Wolden, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S20 - S20
  • [25] Histopathological findings after irradiation and re-irradiation of spinal bone metastases with SBRT
    Forster, R.
    Cho, B. C. J.
    Fahim, D. K.
    Gerszten, P. C.
    Flickinger, J. C.
    Grills, I. S.
    Jawad, M. S.
    Kersh, C. R.
    Letourneau, D.
    Mantel, F.
    Sahgal, A.
    Shin, J. H.
    Winey, B. A.
    Guckenberger, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S181 - S181
  • [26] Use of composite plan with dose effective tool to optimize lung SBRT in re-irradiation setting. Case study
    Soares Rodrigues, J.
    Peguret, N.
    Moeckli, R.
    Heym, L.
    Ozsahin, M.
    Bourhis, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S904 - S905
  • [27] Retrospective analysis of re-irradiation in malignant glioma:: a single-center experience
    Bartsch, R
    Weitmann, HD
    Pennwieser, W
    Wenzel, C
    Muschitz, S
    Baldass, M
    Hassler, M
    Marosi, C
    Rössler, K
    Pötter, R
    Dieckmann, K
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (23-24) : 821 - 826
  • [28] Re-irradiation spine SBRT in oligoprogression breast cancer: A case report
    Rodriguez-Pla, Maria
    Aliaga, Ana
    Gonzalez, Veronica
    Ferrer, Eduardo
    Larrea, Luis
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2022, 35 (04): : 320 - 325
  • [29] Re-irradiation of recurrent intracranial meningiomas: an Italian multicenter retrospective study
    Desideri, I.
    Morelli, I.
    Visani, L.
    Greto, D.
    Detti, B.
    Perini, Z.
    Zivelonghi, E.
    Bulgarelli, G.
    Pinzi, V.
    Navarria, P.
    Clerici, E.
    Ascolese, A. M.
    Anselmo, P.
    Amelio, D.
    Osti, M. F.
    Minniti, G.
    Livi, L.
    Scartoni, D.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S542 - S544
  • [30] Safety and tolerability of liver re-irradiation using high dose SBRT
    Gabrys, D.
    Kulik, R.
    Dolla, L.
    Trela-Janus, K.
    Roch-Zniszczol, A.
    Blamek, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S781 - S781
12345